Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) gained accelerated approval from the U.S. Food and Drug Administration (FDA) for Northera for the treatment of symptomatic neurogenic orthostatic hypotension (NOH). Chelsea Therapeutics expects to launch Northera in the second half of 2014. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) stock opened at $6.65 in last session, and closed at $6.16, while the day range of stock is $5.95 – $6.83. The stock showed a positive/negative weekly performance of 18.69%.
Arrowhead Research Corporation (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, announced the pricing of an underwritten offering of 5.5 million shares of its common stock, offered at a price of $18.95 per share. The offering is expected to close on or about February 24, 2014, subject to customary closing conditions. Arrowhead Research Corp (NASDAQ:ARWR) stock opened at $19.68, in last session and closed at $21.09, by gaining 11.29%. The 52 week range of the stock is $1.65 – $21.74. Company’s market capitalization is $837.00 million.
Lexington-based Agenus Inc. (NASDAQ:AGEN), which is developing novel immunotherapeutics, including anti-cancer vaccines, completed its acquisition of 4-Antibody AG, a private European biopharmaceutical company. Agenus acquired all outstanding stock of 4-Antibody for about 3.3 million shares of Agenus common stock, plus additional contingent payments that may exceed $40 million based on the combined company achieving certain milestones. Agenus intends to continue 4-Antibody’s operations in Basel, Switzerland, and Jena, Germany. Agenus Inc (NASDAQ:AGEN) stock advanced 10.49% and finished the last session at $3.37. The EPS of the stock remained -1.23. Company’s market capitalization is $183.88 million.
ANI Pharmaceuticals, Inc (NASDAQ:ANIP) was a big mover last session, as its shares rose nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. ANI Pharmaceuticals Inc (NASDAQ:ANIP) stock opened the session at $24.10, and closed the session at $26.81. The 52 week range of the stock remained $4.80 – $28.19 and the day range was $24.00 – $28.19.
Leave a Reply